CAP

GLEAM NETWORK CELEBRATES 2 YEARS OF SUCCESS MENTORING PROFESSIONALS IN THE RESTAURANT AND FOODSERVICE INDUSTRY

Retrieved on: 
Wednesday, April 27, 2022
People, CEO, Lifting, Pain, Coffee bean, CAP, The Coffee Bean & Tea Leaf, Brown University International Mentoring Program, Program, Mentorship, Coffee, Veteran, Growth, Global leadership, Career, GLEAM, Female, Learning circle, Facebook, Industry, Blaze Pizza, Pizza Hut, Management, Tutoring, Chipotle, Color

LOS ANGELES, April 27, 2022 /PRNewswire/ -- GLEAM Network, a 501(c)(3) nonprofit organization that offers access to mentoring and leadership development programs for restaurant and foodservice industry professionals, is celebrating its industry impact and success on its second anniversary.

Key Points: 
  • LOS ANGELES, April 27, 2022 /PRNewswire/ -- GLEAM Network , a 501(c)(3) nonprofit organization that offers access to mentoring and leadership development programs for restaurant and foodservice industry professionals, is celebrating its industry impact and success on its second anniversary.
  • GLEAM (Global Leadership Enhancement & Mentorship) Network was founded in April 2020 by Sanjiv Razdan and is run by an all-volunteer team of restaurant industry executives and veterans.
  • "I started GLEAM Network shortly after the pandemic began, when the restaurant industry was experiencing unprecedented pain, to support those who are underserved with career-building resources," said GLEAM Founder and CEO Razdan.
  • "GLEAM is currently the only program of its kind, helping people in the industry rise and develop their careers through mentorship and thus lifting up the industry as a whole."

NEC X Announces Fifth AI Start-up to Graduate from its Corporate Accelerator Program

Retrieved on: 
Tuesday, April 26, 2022
CEO, CAP, Robotics, NEC, Software, Descriptive ethics, Wine, Learning, GLOBE, All rights reserved, Efficiency, Solution, AI, The Wine Group, EIRS, Safety, PALO, Electrical wiring, Silicon

TOKYO and PALO ALTO, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- NEC Corporation, a leader in IT and network technologies, and NEC X , the innovation accelerator for NECs emerging technologies, announced today that Beagle Technology is the fifth startup to graduate from the NEC X Corporate Accelerator Program (CAP).

Key Points: 
  • TOKYO and PALO ALTO, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- NEC Corporation, a leader in IT and network technologies, and NEC X , the innovation accelerator for NECs emerging technologies, announced today that Beagle Technology is the fifth startup to graduate from the NEC X Corporate Accelerator Program (CAP).
  • "Beagle Technology implemented an AI solution in an effort to address the decreasing labor force in the agriculture industry," said Shige Ihara, CEO of NEC X.
  • At the beginning of 2021, I started working with the NEC X program director and researchers to study how to solve this problem.
  • NEC X provides its Corporate Accelerator Program to entrepreneurs-in-residence (EIRs) to fast-track technologies and business ideas brought by EIRs or from inside NEC.

Sigyn Therapeutics Appoints Donald J. Hillebrand, M.D. to its Scientific Advisory Board

Retrieved on: 
Tuesday, April 26, 2022
University Hospitals Cleveland Medical Center, Hepatic encephalopathy, UMKC, University, Luke the Evangelist, CAP, Liver transplantation, U.S. Securities and Exchange Commission, Security (finance), Coronavirus Scientific Advisory Board (Turkey), Editorial board, Annual report, ASAIO Journal, Community-acquired pneumonia, CA, Nature Reviews Gastroenterology & Hepatology, Associate, GLOBE, Death, Risk, Securities Act of 1933, Patient, Sepsis, Inflammation, SAN, OTC Markets Group, Hospital, Infection, Gastroenterology, Securities Exchange Act of 1934, Company, Principal, Iowa State University, European Journal of Gastroenterology & Hepatology, Liver, Book, Section, National Association Medical Staff Services, Therapy, Septic shock, Internal medicine, Pharmaceutical industry, Medicine, Hepatology, Microbiology

to its Scientific Advisory Board.

Key Points: 
  • to its Scientific Advisory Board.
  • Sigyn Therapeutics is a medical technology company focused on the treatment of pathogen-associated conditions that precipitate sepsis, the leading cause of hospital deaths worldwide.
  • This information in this press release contains forward-looking statements of Sigyn Therapeutics, Inc. (Sigyn) that involve substantial risks and uncertainties.
  • All forward-looking statements contained in this report speak only as of the date on which they were made.

American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Now Includes Breast Cancer Index™ to Guide Decisions about Extended Endocrine Therapy

Retrieved on: 
Monday, April 25, 2022
Women, Genetics, Clinical Trials, Other Health, Biotechnology, Managed Care, General Health, Consumer, Health, Oncology, American Joint Committee on Cancer, ASCO, Society, Breast cancer, Recurrence, Osteoporosis, CAP, Woman, European Group, British Columbia Basic Income Expert Panel Report, LDT, Oncology, US Foods, MD, Food, American Society of Clinical Oncology, Bone, Patient, Financial toxicity, Science, Literature, BCI, Nasdaq, American Journal of Clinical Oncology, Journal, ESMO, European Society for Medical Oncology, Safety, Guideline, HOLX, Physician, Decision-making, Quality of life, Disease, Risk, Health, HR, Side, National Disaster Management Authority (India), Medical imaging, Wood-plastic composite, Audit, Cancer, Hologic

Hologic, Inc. (Nasdaq: HOLX) announced today that the American Society of Clinical Oncology (ASCO) has published an update which expands the utility of Breast Cancer Index (BCI) within its Clinical Practice Guideline: Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.

Key Points: 
  • Hologic, Inc. (Nasdaq: HOLX) announced today that the American Society of Clinical Oncology (ASCO) has published an update which expands the utility of Breast Cancer Index (BCI) within its Clinical Practice Guideline: Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.
  • Breast Cancer Index is a molecular, gene expression-based test uniquely positioned to provide information to help physicians individualize treatment decisions for patients with early-stage, HR+ breast cancer.
  • Breast Cancer Index has guideline designation from the American Joint Committee on Cancer for cancer staging based on molecular profile.
  • Breast Cancer Index is intended for routine clinical use, and treatment decisions based on results are the responsibility of the physician.

Kalorama Information to Participate in Dark Report's "Executive War College Conference" Panel on IVD Market, Supply Chain, Labor Shortages

Retrieved on: 
Thursday, April 21, 2022
Dark, Laboratory, CFOS, CAP, COVID-19, Pathology, Current, IVD, Information, Coos, Conference, Pandemic, COVID-19 testing, Publication, Industry, Carlson, Chief executive officer, Darkness, Supply, Marie Cassidy, Pharmaceutical industry, Management, Science

ARLINGTON, Va., April 21, 2022 /PRNewswire-PRWeb/ -- Kalorama Information, part of Science and Medicine Group, will participate in the The Executive War College Conference on Laboratory & Pathology Management, hosted by the Dark Report, April 27-28, 2022 in New Orleans.

Key Points: 
  • ARLINGTON, Va., April 21, 2022 /PRNewswire-PRWeb/ -- Kalorama Information, part of Science and Medicine Group, will participate in the The Executive War College Conference on Laboratory & Pathology Management, hosted by the Dark Report, April 27-28, 2022 in New Orleans.
  • The annual event is attended by hundreds of laboratory and pathology executives and their teams, with information sessions extended roundtables.
  • The Dark Report produces the Executive War College on Laboratory and Pathology Management every spring, which showcases innovations by the nation's and globe's leading laboratory organizations.
  • Kalorama Information recently released a report on at-home testing markets, available at: https://kaloramainformation.com/product/at-home-diagnostic-testing-marke...
    Kalorama Information is a publisher of IVD market information, part of Science and Medicine Group.

JAMA Network Open Publishes Analysis of Results of Two Independent Studies Demonstrating the High Diagnostic Performance of the PrecivityAD™ Blood Test for Alzheimer’s Disease

Retrieved on: 
Thursday, April 21, 2022
General Health, Mental Health, Medical Devices, Other Health, Health, Fillit, Manuscript, Center for Epidemiologic Studies Depression Scale, CEO, Awareness, APS, CAP, Amyloid, Â, Indian Medical Association, Government budget balance, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Research, CLIA, Diagnosis, Alzheimer's disease, Food, Entrepreneurship, Brain, Dementia, District, Patient, Efficiency, Blood, Health, AD, Radiation exposure, Journal, APOE, Physician, Union, Disease, Neurodegeneration, American Medical Association, PET, CSF, Medical device, Medical imaging

The test uses high-resolution mass spectrometry to precisely measure proteins in the blood that indicate the likelihood of amyloid plaques in the brain.

Key Points: 
  • The test uses high-resolution mass spectrometry to precisely measure proteins in the blood that indicate the likelihood of amyloid plaques in the brain.
  • All individuals included in the two studies were experiencing early signs of cognitive impairment or dementia at the time of their evaluation.
  • This is the first time the clinical diagnostic results from our PrecivityAD blood test, as measured in our CAP accredited and CLIA certified lab facility, have been published under rigorous peer-review.
  • The PrecivityAD blood test has the potential to substantially enhance accessibility to a diagnostic tool that doctors can use to evaluate patients presenting with cognitive impairment.

SalesBoost and GF Hotels & Resorts Forge Partnership to Provide Career Advancement Program

Retrieved on: 
Wednesday, April 20, 2022
Adoption, Golf, CAP, Adult, Software, Compliance, Leadership, Learning, Program, LinkedIn, GF, Hotel Management, Ownership, Multimedia, Industry, Partnership, Software as a service, Knowledge, Hotel, Management, Risk management, Tourism

SalesBoost and GF Hotels & Resorts have entered into a strategic partnership for emerging hospitality leaders.

Key Points: 
  • SalesBoost and GF Hotels & Resorts have entered into a strategic partnership for emerging hospitality leaders.
  • The GF CAP is designed as a 12-month program comprised of three tiers: a core program, a professional program, and an expert program.
  • "The GF Hotels & Resorts team members constitute an ideal audience to benefit from the on-demand SalesBoost platform.
  • The SalesBoost solution allows GF Hotels & Resort team members to tap into relevant, role-based content.

InventHelp Inventor Develops Series of Protective Accessories (NAM-128)

Retrieved on: 
Tuesday, April 19, 2022
Head, Neck, Hockey, Injury, Athlete, CAP, PRO, Incidence, Sale, Spine, Safety, Ninth Street, Multimedia, Football, Risk, Sports equipment, Publishing

PITTSBURGH, April 19, 2022 /PRNewswire/ -- "I thought there could be a series of protective accessories to reduce the incidence of injuries caused while playing contact and leisure sports like football, hockey, skateboarding and cycling," said an inventor, from Whites Creek, Tenn., "so I invented the PRO - CAP.

Key Points: 
  • PITTSBURGH, April 19, 2022 /PRNewswire/ -- "I thought there could be a series of protective accessories to reduce the incidence of injuries caused while playing contact and leisure sports like football, hockey, skateboarding and cycling," said an inventor, from Whites Creek, Tenn., "so I invented the PRO - CAP.
  • The patent-pending invention provides a series of accessories to protect the head, frontal/temporal lobes, neck, spine and upper body.
  • The original design was submitted to the Nashville sales office of InventHelp.
  • 20-NAM-128, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

iCura Diagnostics Became The First Fully Qualified Multiplex IHC/IF Service Partner of Akoya Biosciences

Retrieved on: 
Thursday, April 14, 2022
Transcription-mediated amplification, Genetics, Immunohistochemistry, Pennsylvania Department of Corrections, CAP, IHC, Microbiology, CTC, CLIA, Compliance, NGS, Doctor of Philosophy, PCR, Degenerative disease, Contract, Diagnosis, Laboratory, Birth, CRO, Multimedia, Pennsylvania Department of Health, View, Medical imaging

Recently, iCura Diagnostics has been awarded as a fully qualified CRO partner from one of the most widely used multiplexing IHC/IF platform vendor, Akoya Biosciences.

Key Points: 
  • Recently, iCura Diagnostics has been awarded as a fully qualified CRO partner from one of the most widely used multiplexing IHC/IF platform vendor, Akoya Biosciences.
  • This qualifcation confirms and recognized the quality of services provided by iCura and it is the fist of its kind issued by Akoya Biosciences.
  • iCura Diagnostics is conveniently located in Great Valley Industrial Park, the tri-state area outside of Philadelphia, and close to New Jersey, Delaware, as well as Maryland.
  • The company provides diagnostic testing and servcies for the pharmaceutical industry, academic research center, and partner CRO and laboratories.

Premier Medical Laboratory Services Receives College of American Pathologists (CAP) Accreditation

Retrieved on: 
Wednesday, April 13, 2022
Center, CEO, Human services, Food and Drug Administration, CAP, Achievement, DNA sequencing, CDC, College, Centers for Medicare & Medicaid Services, Research, Health, CLIA, Food, Hospital Insurance and Diagnostic Services Act, Science, United States Department of Health and Human Services, NGS, Organization, Doctor of Philosophy, Centers for Disease Control and Prevention timeline, Patient, CMS, Technology, Laboratory, LCMS, Safety, Accreditation, Certification, FDA, Industry, Physician, OSHA, Medicare, University, Medical device, Medicine

GREENVILLE, S.C., April 13, 2022 /PRNewswire/ -- Premier Medical Laboratory Services (PMLS), an advanced medical diagnostic laboratory offering over 2,000 clinical tests, is announcing today their receipt of the College of American Pathologists (CAP) Accreditation .

Key Points: 
  • GREENVILLE, S.C., April 13, 2022 /PRNewswire/ -- Premier Medical Laboratory Services (PMLS), an advanced medical diagnostic laboratory offering over 2,000 clinical tests, is announcing today their receipt of the College of American Pathologists (CAP) Accreditation .
  • As one of the most stringent of laboratory certifications, CAP Accreditation verifies that the laboratory meets all required standards from CLIA, the FDA, and OSHA.
  • In order to receive CAP Accreditation, a laboratory is required to first attain Clinical Laboratory Improvement Amendments (CLIA) certification.
  • Premier Medical Laboratory Services is fully certified by all major accrediting organizations including Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) Accreditation.